Abstract
The development of new vessels plays a critical role in a number of physiological and pathological events such as embryonic development, wound healing, arthritis, and tumor growth and metastasis (1–4). One area that has received considerable attention is determining the role that integrins play in angiogenesis. Recently, we demonstrated that integrin αvβ3 was highly expressed on angiogenic blood vessels associated with a variety of solid tumors and during granulation tissue formation (5,6). Importantly, little if any αvβ3 was detected on quiescent vessels (5,6). In addition, antagonists of αvβ3 were shown to specifically inhibit angiogenesis in vivo. These findings suggest an important role for integrin αvβ3 during neovascularization. Thus, a great deal of attention has been focused on understanding the cellular and molecular mechanisms by which integrins regulate angiogenesis. Angiogenesis can be defined as the process by which new blood vessels form from pre-existing vessels. This process is similar to, but not identical with vasculogenesis, in which new blood vessels arise from blood islands and precursor cells called angioblasts (1–3). Thus, an in-depth understanding of the molecules that regulate this complex biological process is of fundamental importance in both basic and clinical research. In fact, recent advances in our understanding of the molecular and biochemical events that facilitate angiogenesis have provided insight into cellular invasion in general as well as the development of novel strategies for the treatment of neovascular diseases (5,7–11).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Risau, W. and Lemmon, V. (1998) Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev. Biol. 125, 441–450.
D’Amore, P. A. and Thompson, R. W. (1987) Mechanisms of angiogenesis. Annu. Rev. Physiol. 49, 453–464.
Auerbach, W. and Auerbach, R. (1994) Angiogenesis inhibition: a review. Pharmac. Ther. 53, 265–311.
Blood, C. H., and Zetter, B. R. (1990) Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochemica Biophysica Acta. 1032, 89–118.
Brooks, P. C, Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. (1994) Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164.
Brooks, P. C, Clark, R. A. F., and Cheresh, D. A. (1994) Requirement of vascular integrin αvβ3 for angiogenesis. Science 264, 569–571.
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., and Folkman, J. (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348, 555–557.
Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L., Brunting, S., Ferrara, N., Symes, J. F., and Isner, J. M. (1994) Therapeutic angiogenesis. J. Clin. Invest. 93, 662–670.
Baillie, C. T., Winslet, M.C., and Bradley, N. J. (1995) Tumor vasculature a potential therapeutic target. Br. J. Cancer 72, 257–267.
O’Reilly, M. S., Holmgren, L., Shing, Y., Chen, C, Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma. Cell 79, 315–328.
Brooks, P. C. (1997) Integrin αvβ3: a therapeutic target. Drug News and Perspectives 10, 456–461.
Senger, D. R. (1996) Molecular framework for angiogenesis. Am. J. Pathol. 149, 1–7.
Yang, E. Y. and Moses, H. L. (1990) Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol. 111, 731–741.
Iruela-Arispe, M. L., Lane, T. F., Redmond, D., Reilly, M., Bolender, R. P., Kavanagh, T. J., and Sage, E. H. (1995) Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Mol. Biol. Cell. 6, 327–343.
Brooks, P. C. (1996) Role of integrins in angiogenesis. Eur. J. Cancer 32A, 2423–2429.
Grant, D. S., Tashiro, K., Segui-Real, B., Yamada, Y., Martin, G. R., and Kleinman, H. K. (1989) Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58, 933–943.
Davis, C. M., Danehower, S. C, Laurenza, A., and Molony, J. L. (1993) Identification of a role of the vitronectin receptor and protein kinase C in the induction of endothelial cell vascular formation. J. Cell. Biochem. 51, 206–218.
Dvorak, H. F., Harvey, V. S., Estrella, P., Brown, L. F., Mcdonagh, J., and Dvorak, A. M. (1987) Fibrin containing gels induce angiogenesis. Lab. Invest. 57, 673–686.
Montesano, R., Orci, L., and Vassalli, P. (1983) In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J. Cell. Biol. 97, 1648–1652.
Nicosia, R. F. and Ottinetti, A. (1990) Growth of mircovessels in serum free matrix culture of aorta: a quantitative assay of angiogenesis in vitro. Lab. Invest. 63, 115–122.
Brown, K. J., Maynes, S. F., Bezos, A., Maguire, D. J., Ford, M. D., and Parish, C. R. (1996) A novel in vitro assay for human angiogenesis. Lab. Invest. 75, 539–555.
Frater-Schroder, M., Risau, W., Hallmann, R., Gautschi, P., and Bohlen, P. (1987) Tumor necrosis factor type a, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84, 5277–5281.
Sholley, M. M., Ferguson, G. P., Seibel, H. R., Montour, J. L., and Wilson, J. D. (1994) Mechanisms of neovascularization. Lab. Invest. 51, 624–634.
Friedlander, M., Brooks, P. C, Shaffer, R. W., Kincaid, C. M., Varner, J. A., and Cheresh, D. A. (1995) Definition of two angiogenic pathways by distinct αv integrins. Science 270, 1500–1502.
Chen, C, Parangi, S., Tolentino, M. J., and Folkman, J. (1995) A strategy to discover circulating angiogenesis inhibitors generated by human tumors. Cancer Res. 55, 4230–4233.
Miller, J. W., Adamis, A. P., Shima, D. T., D’Amore, P. A., Moulton, R. S., O’Reilly, M. S., Folkman, J., Dvorak, H. F., Brown, L. F., Beres, B., Yeo, T., and Yeo, K. (1994) Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J. Pathol. 145, 574–584.
Brooks, P. C, Stromblad, S., Klemke, R., Visscher, D., Sarkar, F. H., and Cheresh, D. A. (1995) Anti-Integrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96, 1815–1822.
Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J., A., Pauly, R. R., Grant, D. S., and Martin, G. R. (1992) A simple quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519–527.
Nguyen, M., Shing, Y., and Folkman, J. (1994) Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc. Res. 47, 31–40.
Rizzo, V. and Defouw, D. O. (1993) Macromolecular selectivity of chick chorioallantoic membrane microvessels during normal angiogenesis and endothelial differentiation. Tissue Cell 25, 847–856.
Leeson, T. S., and Leeson, C. R. (1963) The chorioallantois of the chick: light and electron microscopic observations at various times of incubation. J. Anat. Lond. 97, 585–595.
Flamme, I. (1989) Is extraembryonic angiogenesis in the chick embryo controlled by the endoderm. Anat. Embryol. 180, 259–272.
Ausprunk, D. H., Knighton, D. R., and Folkman, J. (1974) Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev. Biol. 38, 237–247.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc.
About this protocol
Cite this protocol
Brooks, P.C., Montgomery, A.M.P., Cheresh, D.A. (1999). Use of the 10-Day-Old Chick Embryo Model for Studying Angiogenesis. In: Howlett, A. (eds) Integrin Protocols. Methods in Molecular Biology, vol 129. Humana Press. https://doi.org/10.1385/1-59259-249-X:257
Download citation
DOI: https://doi.org/10.1385/1-59259-249-X:257
Publisher Name: Humana Press
Print ISBN: 978-0-89603-569-0
Online ISBN: 978-1-59259-249-4
eBook Packages: Springer Protocols